Involvement of PPAR receptors in the anticonvulsant effects of a cannabinoid agonist, WIN 55,212-2 B Payandemehr, A Ebrahimi, R Gholizadeh, R Rahimian, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 57, 140-145, 2015 | 47 | 2015 |
Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55. 2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized … P Tabarsi, N Anjidani, R Shahpari, M Mardani, A Sabzvari, B Yazdani, ... Clinical Microbiology and Infection 29 (2), 215-220, 2023 | 37 | 2023 |
Role of nitric oxide in additive anticonvulsant effects of agmatine and morphine B Payandemehr, R Rahimian, A Bahremand, A Ebrahimi, S Saadat, ... Physiology & behavior 118, 52-57, 2013 | 35 | 2013 |
The role of 5-HT3 receptors in the additive anticonvulsant effects of citalopram and morphine on pentylenetetrazole-induced clonic seizures in mice A Bahremand, B Payandemehr, R Rahimian, P Ziai, N Pourmand, ... Epilepsy & Behavior 21 (2), 122-127, 2011 | 35 | 2011 |
Additive anticonvulsant effects of agmatine and lithium chloride on pentylenetetrazole-induced clonic seizure in mice: involvement of α2-adrenoceptor A Bahremand, P Ziai, B Payandemehr, R Rahimian, A Amouzegar, ... European journal of pharmacology 666 (1-3), 93-99, 2011 | 20 | 2011 |
Protective effects of lithium chloride on seizure susceptibility: Involvement of α2-adrenoceptor B Payandemehr, A Bahremand, A Ebrahimi, SE Nasrabady, R Rahimian, ... Pharmacology Biochemistry and Behavior 133, 37-42, 2015 | 18 | 2015 |
Comparative immunogenicity and safety of SpikoGen®, a recombinant SARS-CoV-2 spike protein vaccine in children and young adults: an immuno-bridging clinical trial P Tabarsi, S Mamishi, N Anjidani, R Shahpari, H Kafi, N Fallah, B Yazdani, ... International Immunopharmacology 127, 111436, 2024 | 4 | 2024 |